Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-30

Clinical Trial Update: A Study of 18F-AV-45 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study of 18F-AV-45 (florbetapir F-18) in healthy volunteers to assess safety and pharmacokinetics; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMYVID (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2012-04-30